This new Aramchol formulation was co-developed by Galmed and Barcode Nanotech, based on Barcode Nanotech's unique and proprietary platform which enables simultaneous screening of hundreds of different ...

Overcoming common challenges with today’s biologics, such as developing devices for high-concentration subcutaneous ...

Nearly half of all drug shortages in 2022 were caused by quality issues or manufacturing delays, according to the Center for Drug Evaluation and Research (CDER). Evaluating the critical quality ...

A problem for biopharmaceutical companies comes as degraded proteins lead to ineffective and possibly dangerous medicines for their clients. Drug companies work on formulation development to protect ...

Galmed Pharmaceuticals Ltd. GLMD shares are trading higher after the company announced the development of a brain penetrating ...

An important parameter is the aggregation pattern when exposed to thermal stress, as this can give us a better understanding as needed for problem-solving during formulation development. To assess the ...

Forced degradation studies involve exposing a drug substance to harsher conditions than the product would be expected to experience and determining at what point and how it degrades. Identifying ...

In this free webinar, see how formulation decisions directly impact Critical Quality Attributes. Attendees will learn how comprehensive analytical data informs robust control strategy development. The ...

Understand the challenges of liquid injectables and discover strategies to prevent stability issues and regulatory delays.

WOBURN, Mass.--(BUSINESS WIRE)--ReForm Biologics, a pharmaceutical technology company developing innovative biologic formulations to improve drug delivery and manufacturing, expanded its patent ...

Monoclonal antibodies have become one of the most established and clinically successful therapeutic modalities, supported by decades of advances in discovery, engineering, and manufacturing. Many ...